An Amazon bestseller promotes MLS® for curing chronic headaches

09 October 2018 - Trade fairs & Congresses -

Break Away – The New Method for Treating Chronic Headaches, Migraines and TMJ Without Medication”, an Amazon-Bestseller written by Doctor Fred Abeles, a leading worldwide expert in curing chronic headache and temporo-mandibular issues has no doubts: MLS® is decisive in checkmating migraines and headaches, thereby avoiding the massive use of medication.

The merits of the ASAlaser therapy were outlined by the self-same specialist during an interview with “Daytime” on Channel 8 (a digital channel based in Florida). In addition to being a successful author, the Doctor is also a Director of the “Atlanta Center for TMJ” and the Regional Director of the “Las Vegas Institute for Advanced Dental Studies”.

“I have no doubts, – he explained – nothing compares with this therapy in terms of effectiveness and safety. MLS® Laser Therapy is based on using the homonymous impulse, the result of two combined and synchronised laser emissions which are exploited simultaneously and safely, thereby maximising the obtainable results of pain reduction. In practical terms, MLS® produces controlled and non-dangerous thermal effects, stimulates biochemical reactions and vasodilation, increasing the supply of oxygen and nutrients to the treated area. The moderate vasodilation helps to resolve the inflammatory process. An out-and-out innovation which allows treating chronic headaches, migraines, but also temporo-mandibular issues without medicines, quickly and with no contraindications”.

A pioneer in the field of chronic pain, Doctor Fred Abeles therefore promotes MLS® Laser Therapy as a new frontier of “pain management”, also defining it as a “major technological innovation, using a high-performance robotised device for its application”, produced in Italy by ASAlaser.

You might also be interested in ...

See all articles

ASAlaser and Asian Star @ KIMES 2024
News - 15/04/2024
Thus, the company staff once again flew to Seoul to take part in the 2024 edition of Kimes, where the flagship devices were displayed.
ASAlaser @ FIF Milano 2024
News - 19/03/2024
Not only top-of-the-line devices, including the new HIRO and M-Hi as well as Magneto Qs and M8, but also three workshops aimed at highlighting the strengths of its therapies.
ASA tema @ ArabHealth 2024
News - 15/02/2024
In order to provide maximum visibility and the best dissemination of the strengths of its Therapeutic Solutions, the company preceded its attendance at the fair (Dubai, 29th January – 1st February)...
Blog - 11/09/2024
This research, conducted using the M6 robotic device, is the first of its kind to explore this application, offering new hope to patients suffering from this debilitating side effect of radiotherapy.
Press - 09/09/2024
Benefits, training and initiatives aimed at improving not just the working day are the basis of ASA’s 2024 welfare plan which considers its collaborators’ well-being a trump card.
Press - 05/09/2024
The Colombian newspaper in Barranquilla “Notas de actualidad” has no doubts: the “made in Italy” M8 laser device allows reducing pain and restoring the best quality of life to patients suffering from...